WNRC Wenr Corporation (CE)

St. Paul Pharmaceutical, a pending merger partner with WENR Corp. (OTC:WNRC) (wenr.net), announced today that it named Henry Smith, Ph.D., as CEO of St. Paul Pharmaceutical Corp. Dr. Smith has directed diverse teams of Medical, Scientific and Marketing personnel within both large and small companies. He has over 30 years management experience in all aspects of company operations, from research scientist to CEO. Dr. Smith has set up and registered several laboratories with the FDA. Also, he developed SOP and GMP protocols for reference laboratories and a medical device manufacturing facility. Furthermore, he obtained 510(k) registration with the FDA and Notice of Compliance with HPB (Canada) for diagnostic assays. He is an expert in developing various immunodiagnostic assays and has expertise in determining clinical validity, accuracy, reproducibility, stability, safety and quality control procedures. He has given lectures on research findings to scientists, made sales promotions on company products to medical professionals and investment presentations to stockbrokers. As President and CEO of Allied Biotechnology International, Inc., Dr. Smith's Responsibilities involved all aspects of running a publicly held biotechnology company. Products under development included a variety of OTC diagnostic assays and a water purification system. Previously, as Chief Operations Officer of Specialty Medical Industries, Inc., he did hands-on research to develop a wide variety of diagnostic assays and a matched multifunction spectrophotometer. Dr. Smith earned a Ph.D. in Immunology from the University of Leeds School of Medicine, England. His thesis was entitled "Immunological Phenomena and Cancer." He earned a B.Sc. (Honors) in General Science University of London, England. St. Paul Pharmaceutical is a manufacturer and distributor of pharmaceuticals with locations in Viet Nam, Canada and California. Recently, the Company has signed a letter of intent to merge with WENR Corp. Both St. Paul and WENR Corp. are working towards an anticipated completion of the merger in October. WENR Corporation is a holding company that acquires technology and technology companies. It provides senior management assistance for product and market development and secures working capital. The foregoing contains forward-looking information within the meaning of The Private Securities Litigation Act of 1995. Such forward-looking statements involve certain risks and uncertainties. The actual results may differ materially from such forward-looking statements. The company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results (expressed or implied) will not be realized.